CVE-2024-53355

Public Exploit

Description

Multiple incorrect access control issues in EasyVirt DCScope <= 8.6.0 and CO2Scope <= 1.3.0 allows remote authenticated attackers, with low privileges, to (1) add an admin user via the /api/user/addalias route; (2) modifiy a user via the /api/user/updatealias route; (4) delete users via the /api/user/delalias route; (4) get users via the /api/user/aliases route; (5) add a root group via the /api/user/adduser route; (6) modifiy a group via the /api/user/updateuser route; (7) delete a group via the /api/user/deluser route; (8) get groups via the /api/user/users route; (9) add an admin role via the /api/user/addrole route; (10) modifiy a role via the /api/user/updaterole route; (11) delete a role via the /api/user/delrole route; (12) get roles via the /api/user/roles route.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.13%
Third-Party Advisory github.com
Affected: n/a n/a
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-53355?
CVE-2024-53355 has been scored as a high severity vulnerability.
How to fix CVE-2024-53355?
To fix CVE-2024-53355, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-53355 being actively exploited in the wild?
It is possible that CVE-2024-53355 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.